Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.

Poma AM, Torregrossa L, Bruno R, Basolo F, Fontanini G.

Sci Rep. 2018 Jul 13;8(1):10623. doi: 10.1038/s41598-018-28928-3.

2.

Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without 131I Ablation.

Matrone A, Latrofa F, Torregrossa L, Piaggi P, Gambale C, Faranda A, Ricci D, Agate L, Molinaro E, Basolo F, Vitti P, Elisei R.

Thyroid. 2018 Jul;28(7):871-879. doi: 10.1089/thy.2018.0080.

PMID:
29860933
3.

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.

Romei C, Tacito A, Molinaro E, Piaggi P, Cappagli V, Pieruzzi L, Matrone A, Viola D, Agate L, Torregrossa L, Ugolini C, Basolo F, De Napoli L, Curcio M, Ciampi R, Materazzi G, Vitti P, Elisei R.

Oncol Lett. 2018 Jun;15(6):9174-9182. doi: 10.3892/ol.2018.8470. Epub 2018 Apr 12.

4.

Cell differentiation in cardiac myxomas: confocal microscopy and gene expression analysis after laser capture microdissection.

Pucci A, Mattioli C, Matteucci M, Lorenzini D, Panvini F, Pacini S, Ippolito C, Celiento M, De Martino A, Dolfi A, Belgio B, Bortolotti U, Basolo F, Bartoloni G.

Heart Vessels. 2018 May 22. doi: 10.1007/s00380-018-1189-2. [Epub ahead of print]

PMID:
29789901
5.

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.

Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, Durante C, Elisei R, Fadda G, Frasoldati A, Fugazzola L, Guglielmi R, Lombardi CP, Miccoli P, Papini E, Pellegriti G, Pezzullo L, Pontecorvi A, Salvatori M, Seregni E, Vitti P.

J Endocrinol Invest. 2018 Jul;41(7):849-876. doi: 10.1007/s40618-018-0884-2. Epub 2018 May 4.

PMID:
29729004
6.

Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy.

Rotondo Dottore G, Torregrossa L, Caturegli P, Ionni I, Sframeli A, Sabini E, Menconi F, Piaggi P, Sellari-Franceschini S, Nardi M, Latrofa F, Vitti P, Marcocci C, Basolo F, Marinò M.

JAMA Ophthalmol. 2018 Jun 1;136(6):613-619. doi: 10.1001/jamaophthalmol.2018.0806.

PMID:
29710102
7.

The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.

Macerola E, Rago T, Proietti A, Basolo F, Vitti P.

J Endocrinol Invest. 2018 Apr 27. doi: 10.1007/s40618-018-0895-z. [Epub ahead of print]

PMID:
29704233
8.

Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.

Condello V, Macerola E, Ugolini C, De Napoli L, Romei C, Materazzi G, Elisei R, Basolo F.

Head Neck. 2018 Mar 22. doi: 10.1002/hed.25155. [Epub ahead of print]

PMID:
29566452
9.

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases.

Romei C, Ciampi R, Casella F, Tacito A, Torregrossa L, Ugolini C, Basolo F, Materazzi G, Vitti P, Elisei R.

Oncotarget. 2018 Jan 4;9(11):9875-9884. doi: 10.18632/oncotarget.23986. eCollection 2018 Feb 9.

10.

A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma.

Parascandolo A, Laukkanen MO, De Rosa N, Ugolini C, Cantisani MC, Cirafici AM, Basolo F, Santoro M, Castellone MD.

Oncotarget. 2017 Dec 17;9(4):4496-4510. doi: 10.18632/oncotarget.23388. eCollection 2018 Jan 12.

11.

TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.

Insilla AC, Proietti A, Borrelli N, Macerola E, Niccoli C, Vitti P, Miccoli P, Basolo F.

Oncol Lett. 2018 Mar;15(3):2763-2770. doi: 10.3892/ol.2017.7675. Epub 2017 Dec 21.

12.

A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma.

Poma AM, Giannini R, Piaggi P, Ugolini C, Materazzi G, Miccoli P, Vitti P, Basolo F.

Endocr Connect. 2018 Jan;7(1):124-132. doi: 10.1530/EC-17-0261.

13.

miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells.

Balia C, Giordano M, Scalise V, Neri T, Fontanini G, Basolo F, Celi A, Pedrinelli R.

Thrombosis. 2017;2017:1076397. doi: 10.1155/2017/1076397. Epub 2017 Oct 30.

14.

Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms.

Proietti A, Sartori C, Macerola E, Borrelli N, Materazzi G, Vitti P, Basolo F.

Virchows Arch. 2017 Dec;471(6):769-773. doi: 10.1007/s00428-017-2236-6. Epub 2017 Oct 3.

PMID:
28975450
15.

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer.

Di Desidero T, Antonelli A, Orlandi P, Ferrari SM, Fioravanti A, Alì G, Fontanini G, Basolo F, Francia G, Bocci G.

Cancer Lett. 2017 Dec 28;411:35-43. doi: 10.1016/j.canlet.2017.09.032. Epub 2017 Sep 28.

PMID:
28964784
16.

KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.

Viola D, Giani C, Mazzeo S, Ugolini C, Ciampi R, Molinaro E, Agate L, Borrelli N, Chella A, Fontanini G, Basolo F, Elisei R.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3091-3096. doi: 10.1210/jc.2017-00304.

PMID:
28911147
17.

Differences in miRNA expression profiles between wild-type and mutated NIFTPs.

Denaro M, Ugolini C, Poma AM, Borrelli N, Materazzi G, Piaggi P, Chiarugi M, Miccoli P, Vitti P, Basolo F.

Endocr Relat Cancer. 2017 Oct;24(10):543-553. doi: 10.1530/ERC-17-0167.

PMID:
28830935
18.

Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report.

Pani F, Macerola E, Basolo F, Boi F, Scartozzi M, Mariotti S.

Oncol Lett. 2017 Aug;14(2):2186-2190. doi: 10.3892/ol.2017.6395. Epub 2017 Jun 16.

19.

The Molecular Landscape of Noninvasive Follicular Thyroid Neoplasm With Papillary-like Nuclear Features (NIFTP): A Literature Review.

Basolo F, Macerola E, Ugolini C, Poller DN, Baloch Z.

Adv Anat Pathol. 2017 Sep;24(5):252-258. doi: 10.1097/PAP.0000000000000163. Review.

PMID:
28777140
20.

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, Materazzi G, Sellari-Franceschini S, Ribechini A, Torregrossa L, Basolo F, Vitti P, Elisei R.

Nat Rev Endocrinol. 2017 Nov;13(11):644-660. doi: 10.1038/nrendo.2017.76. Epub 2017 Jul 14. Review.

PMID:
28707679
21.

Identification of Two Distinct Molecular Subtypes of Non-Invasive Follicular Neoplasm with Papillary-Like Nuclear Features by Digital RNA Counting.

Giannini R, Ugolini C, Poma AM, Urpì M, Niccoli C, Elisei R, Chiarugi M, Vitti P, Miccoli P, Basolo F.

Thyroid. 2017 Oct;27(10):1267-1276. doi: 10.1089/thy.2016.0605. Epub 2017 Sep 5.

PMID:
28679352
22.

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, Bihl M, Bubendorf L, Salto-Tellez M, de Biase D, Tallini G, Hwang DH, Sholl LM, Luthra R, Weynand B, Vander Borght S, Missiaglia E, Bongiovanni M, Stieber D, Vielh P, Schmitt F, Rappa A, Barberis M, Pepe F, Pisapia P, Serra N, Vigliar E, Bellevicine C, Fassan M, Rugge M, de Andrea CE, Lozano MD, Basolo F, Fontanini G, Nikiforov YE, Kamel-Reid S, da Cunha Santos G, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group.

Cancer Cytopathol. 2017 Aug;125(8):615-626. doi: 10.1002/cncy.21868. Epub 2017 May 5.

PMID:
28475299
23.

Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.

Vecchio G, Parascandolo A, Allocca C, Ugolini C, Basolo F, Moracci M, Strazzulli A, Cobucci-Ponzano B, Laukkanen MO, Castellone MD, Tsuchida N.

Oncotarget. 2017 Apr 18;8(16):27075-27092. doi: 10.18632/oncotarget.15635.

24.

MicroRNA-based molecular classification of papillary thyroid carcinoma.

Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M.

Int J Oncol. 2017 May;50(5):1767-1777. doi: 10.3892/ijo.2017.3960. Epub 2017 Apr 7.

PMID:
28393181
25.

Molecular genetic features and risk assessment in a series of 30 patients who underwent an operation for gastrointestinal stormal tumours.

Bartalucci A, Pouli E, Fregoli L, Cremonini C, Basolo F, Miccoli P, Chiarugi M.

S Afr J Surg. 2016 Mar;54(1):23-27.

PMID:
28240492
26.

BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report.

Macerola E, Torregrossa L, Ugolini C, Bakkar S, Vitti P, Fadda G, Basolo F.

Int J Surg Pathol. 2017 Jun;25(4):348-351. doi: 10.1177/1066896916688083. Epub 2017 Jan 23.

PMID:
28112041
27.

Intimal Sarcoma of the Descending Aorta Mimicking Aortitis.

Pucci A, De Martino A, Levantino M, Berchiolli R, Basolo F, Bortolotti U.

Aorta (Stamford). 2016 Aug 1;4(4):142-145. doi: 10.12945/j.aorta.2016.16.022. eCollection 2016 Aug.

28.

Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer.

Abd Elmageed ZY, Sholl AB, Tsumagari K, Al-Qurayshi Z, Basolo F, Moroz K, Boulares AH, Friedlander P, Miccoli P, Kandil E.

Surgery. 2017 Apr;161(4):1122-1128. doi: 10.1016/j.surg.2016.06.081. Epub 2016 Dec 2.

PMID:
27919446
29.

Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report.

Torregrossa L, Rotondo MI, Cacciato Insilla A, Galleri D, Guidoccio F, Miccoli P, Livolsi VA, Basolo F.

Oncol Lett. 2016 Nov;12(5):3224-3228. Epub 2016 Aug 31.

30.

Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1.

Rago T, Scutari M, Loiacono V, Santini F, Tonacchera M, Torregrossa L, Giannini R, Borrelli N, Proietti A, Basolo F, Miccoli P, Piaggi P, Latrofa F, Vitti P.

Thyroid. 2017 Jan;27(1):103-110. doi: 10.1089/thy.2016.0341. Epub 2016 Dec 21.

PMID:
27809694
31.

Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.

Torregrossa L, Viola D, Sensi E, Giordano M, Piaggi P, Romei C, Materazzi G, Miccoli P, Elisei R, Basolo F.

J Clin Endocrinol Metab. 2016 Nov;101(11):4413-4420. Epub 2016 Aug 29.

PMID:
27571181
32.

Role of YAP-1 in Thyroid Tumor Progression and Outcome.

Ugolini C, Borrelli N, Niccoli C, Elisei R, Viola D, Vitti P, Miccoli P, Basolo F.

Appl Immunohistochem Mol Morphol. 2017 Sep;25(8):581-585. doi: 10.1097/PAI.0000000000000344.

PMID:
27753655
33.

TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.

Orlandella FM, Di Maro G, Ugolini C, Basolo F, Salvatore G.

Oncotarget. 2016 Oct 25;7(43):70575-70588. doi: 10.18632/oncotarget.12129.

34.

Lipomatous hamartoma-like lesion of a bicuspid aortic valve: an incidental surgical finding.

De Martino A, Blasi S, Lorenzini D, Fornaro M, Basolo F, Bortolotti U, Pucci A.

Cardiovasc Pathol. 2016 Nov - Dec;25(6):500-502. doi: 10.1016/j.carpath.2016.08.006. Epub 2016 Aug 28.

PMID:
27619733
35.

Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior.

Bacca A, Pucci A, Lorenzini D, Chiacchio S, Volterrani D, Ferrari M, Sellari Franceschini S, Materazzi G, Basolo F, Bernini G.

Q J Nucl Med Mol Imaging. 2016 Sep 2. [Epub ahead of print]

PMID:
27589008
36.

miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.

Borrelli N, Denaro M, Ugolini C, Poma AM, Miccoli M, Vitti P, Miccoli P, Basolo F.

Mod Pathol. 2017 Jan;30(1):39-51. doi: 10.1038/modpathol.2016.157. Epub 2016 Sep 2.

37.

Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

Ciampi R, Romei C, Pieruzzi L, Tacito A, Molinaro E, Agate L, Bottici V, Casella F, Ugolini C, Materazzi G, Basolo F, Elisei R.

J Endocrinol Invest. 2017 Jan;40(1):55-62. doi: 10.1007/s40618-016-0526-5. Epub 2016 Aug 17.

PMID:
27535135
38.

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.

Romei C, Casella F, Tacito A, Bottici V, Valerio L, Viola D, Cappagli V, Matrone A, Ciampi R, Piaggi P, Ugolini C, Torregrossa L, Basolo F, Materazzi G, Vitti P, Elisei R.

J Med Genet. 2016 Nov;53(11):729-734. doi: 10.1136/jmedgenet-2016-103833. Epub 2016 Jul 28.

PMID:
27468888
39.

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology.

Baloch ZW, Seethala RR, Faquin WC, Papotti MG, Basolo F, Fadda G, Randolph GW, Hodak SP, Nikiforov YE, Mandel SJ.

Cancer Cytopathol. 2016 Sep;124(9):616-20. doi: 10.1002/cncy.21744. Epub 2016 May 20. No abstract available.

40.

Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.

Maletta F, Massa F, Torregrossa L, Duregon E, Casadei GP, Basolo F, Tallini G, Volante M, Nikiforov YE, Papotti M.

Hum Pathol. 2016 Aug;54:134-42. doi: 10.1016/j.humpath.2016.03.014. Epub 2016 Apr 13.

41.

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA.

JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.

42.

A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.

Cantisani MC, Parascandolo A, Perälä M, Allocca C, Fey V, Sahlberg N, Merolla F, Basolo F, Laukkanen MO, Kallioniemi OP, Santoro M, Castellone MD.

Oncotarget. 2016 May 10;7(19):28510-22. doi: 10.18632/oncotarget.8577.

43.

Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.

Borsari S, Pardi E, Pellegata NS, Lee M, Saponaro F, Torregrossa L, Basolo F, Paltrinieri E, Zatelli MC, Materazzi G, Miccoli P, Marcocci C, Cetani F.

Endocrine. 2017 Feb;55(2):386-397. doi: 10.1007/s12020-016-0941-6. Epub 2016 Apr 2.

PMID:
27038812
44.

'Incidental' and 'non-incidental' thyroid papillary microcarcinomas are two different entities.

Provenzale MA, Fiore E, Ugolini C, Torregrossa L, Morganti R, Molinaro E, Miccoli P, Basolo F, Vitti P.

Eur J Endocrinol. 2016 Jun;174(6):813-20. doi: 10.1530/EJE-15-1223. Epub 2016 Mar 31.

45.

Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.

Borrelli N, Ugolini C, Giannini R, Antonelli A, Giordano M, Sensi E, Torregrossa L, Fallahi P, Miccoli P, Basolo F.

Cancer Cytopathol. 2016 May;124(5):340-9. doi: 10.1002/cncy.21681. Epub 2016 Jan 7.

46.

Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.

De Napoli L, Bakkar S, Ambrosini CE, Materazzi G, Proietti A, Macerola E, Basolo F, Miccoli P.

Thyroid. 2016 Mar;26(3):390-4. doi: 10.1089/thy.2015.0311. Epub 2015 Dec 9.

PMID:
26548748
47.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ, Al-Kuraya K, Fugazzola L, Colombo C, Kebebew E, Jarzab B, Czarniecka A, Bendlova B, Sykorova V, Sobrinho-Simões M, Soares P, Shong YK, Kim TY, Cheng S, Asa SL, Viola D, Elisei R, Yip L, Mian C, Vianello F, Wang Y, Zhao S, Oler G, Cerutti JM, Puxeddu E, Qu S, Wei Q, Xu H, O'Neill CJ, Sywak MS, Clifton-Bligh R, Lam AK, Riesco-Eizaguirre G, Santisteban P, Yu H, Tallini G, Holt EH, Vasko V, Xing M.

J Clin Endocrinol Metab. 2016 Jan;101(1):264-74. doi: 10.1210/jc.2015-2917. Epub 2015 Nov 3.

48.

A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule.

Cetani F, Frustaci G, Torregrossa L, Magno S, Basolo F, Campomori A, Miccoli P, Marcocci C.

World J Surg Oncol. 2015 Sep 8;13:270. doi: 10.1186/s12957-015-0672-9.

49.

Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.

Macerola E, Loggini B, Giannini R, Garavello G, Giordano M, Proietti A, Niccoli C, Basolo F, Fontanini G.

Virchows Arch. 2015 Aug;467(2):177-84. doi: 10.1007/s00428-015-1784-x. Epub 2015 Jun 9.

PMID:
26055532
50.

Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.

Elisei R, Lorusso L, Piaggi P, Torregrossa L, Pellegrini G, Molinaro E, Agate L, Bottici V, Pani F, Cacciato Insilla A, Casella F, Ciampi R, Tognetti I, Materazzi G, Basolo F, Romei C.

Eur J Endocrinol. 2015 Sep;173(3):297-304. doi: 10.1530/EJE-15-0304. Epub 2015 Jun 1.

Supplemental Content

Loading ...
Support Center